Teva Pharma (TEVA) Tops Q1 EPS by 4c, Revenues Miss; Offers FY21 EPS/Revenue Guidance
Go back to Teva Pharma (TEVA) Tops Q1 EPS by 4c, Revenues Miss; Offers FY21 EPS/Revenue Guidance| TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) | Delayed: 33.10 +0.90 (2.80%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $32.20 | 52 Week High | $66.55 | |||
| Open | $32.14 | 52 Week Low | $37.82 | |||
| Day High | $33.13 | P/E | N/A | |||
| Day Low | $32.12 | EPS | $0.00 | |||
| Volume | 1,268,348 | |||||
